NOVO-B.CO | Novo Nordisk A/S Annual & Quarterly Balance

Annual Balance Sheets

(In DKK)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	314.48 Billion	241.25 Billion	194.5 Billion	144.92 Billion	125.61 Billion	110.76 Billion
Total Current Assets	139.64 Billion	108.19 Billion	85.59 Billion	65.8 Billion	62.45 Billion	59.06 Billion
Cash And Short Term Investments	30.23 Billion	23.57 Billion	17.48 Billion	12.75 Billion	15.47 Billion	15.63 Billion
Cash and Cash Equivalents	14.39 Billion	12.65 Billion	10.72 Billion	12.75 Billion	15.47 Billion	15.63 Billion
Short Term Investments	15.83 Billion	10.92 Billion	6.76 Billion	-	-	-
Net Receivables	75.26 Billion	57.5 Billion	46.79 Billion	32.18 Billion	29.15 Billion	26.88 Billion
Inventory	31.81 Billion	24.38 Billion	19.62 Billion	18.53 Billion	17.64 Billion	16.33 Billion
Other Current Assets	2.34 Billion	2.72 Billion	1.69 Billion	2.33 Billion	188 Million	204 Million
Total Non-Current Assets	174.84 Billion	133.06 Billion	108.91 Billion	79.11 Billion	63.15 Billion	51.7 Billion
Net PPE	90.96 Billion	66.67 Billion	55.36 Billion	50.26 Billion	50.55 Billion	41.89 Billion
Good Will And Intangible Assets	60.4 Billion	51.41 Billion	43.17 Billion	20.65 Billion	5.83 Billion	5.14 Billion
Good Will	4.46 Billion	5.09 Billion	4.34 Billion	-	-	-
Intangible Assets	55.94 Billion	46.32 Billion	38.82 Billion	20.65 Billion	5.83 Billion	5.14 Billion
Long-Term Investments	1.66 Billion	1.34 Billion	1.44 Billion	1.64 Billion	1.8 Billion	1.77 Billion
Tax Assets	20.38 Billion	13.42 Billion	8.67 Billion	5.86 Billion	4.12 Billion	2.89 Billion
Other Non Current Assets	1.43 Billion	206 Million	267 Million	674 Million	841 Million	-
Other Assets	-	-	-	-	-	-
Total Liabilities	207.92 Billion	157.77 Billion	123.76 Billion	81.59 Billion	68.01 Billion	58.93 Billion
Total Current Liabilities	169.65 Billion	120.94 Billion	99.51 Billion	70.27 Billion	58.98 Billion	54.16 Billion
Account Payables	25.6 Billion	15.58 Billion	8.87 Billion	5.71 Billion	6.35 Billion	6.75 Billion
Tax Payables	7.11 Billion	7.09 Billion	3.65 Billion	3.91 Billion	4.21 Billion	5.04 Billion
Short Term Debt	6.47 Billion	1.46 Billion	13.68 Billion	7.45 Billion	1.47 Billion	515 Million
Deferred Revenue	107.59 Billion	-	55.17 Billion	38.72 Billion	35.33 Billion	44.86 Billion
Other Current Liabilities	29.97 Billion	103.88 Billion	21.78 Billion	18.37 Billion	15.81 Billion	2.02 Billion
Total Non Current Liabilities	38.27 Billion	36.83 Billion	24.24 Billion	11.32 Billion	9.03 Billion	4.76 Billion
Long-Term Debt	20.52 Billion	24.31 Billion	12.96 Billion	2.89 Billion	3 Billion	-
Deferred Revenue Non Current	7.39 Billion	-	5.65 Billion	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	189 Million	5.45 Billion	360 Million	5.92 Billion	5.94 Billion	4.64 Billion
Other Liabilities	-	-	-	-	-	-
Total Equity	106.56 Billion	83.48 Billion	70.74 Billion	63.32 Billion	57.59 Billion	51.83 Billion
Stock Holders Equity	106.56 Billion	83.48 Billion	70.74 Billion	63.32 Billion	57.59 Billion	51.83 Billion
Common Stock	451 Million	456 Million	462 Million	470 Million	480 Million	490 Million
Retained Earnings	104.83 Billion	80.58 Billion	72 Billion	63.77 Billion	57.81 Billion	53.4 Billion
Accumulated other comprehensive income	1.27 Billion	2.44 Billion	-1.71 Billion	-911 Million	-694 Million	-2.04 Billion
Common Stock Equity	106.56 Billion	83.48 Billion	70.74 Billion	63.32 Billion	57.59 Billion	51.83 Billion
Capital Lease Obligation	5.72 Billion	4.52 Billion	4.12 Billion	3.67 Billion	3.82 Billion	-
Total Investments	17.5 Billion	12.26 Billion	8.2 Billion	1.64 Billion	1.8 Billion	1.77 Billion
Total Debt	27 Billion	25.78 Billion	26.64 Billion	10.35 Billion	4.48 Billion	515 Million
Net Debt	12.61 Billion	13.13 Billion	15.92 Billion	-2.4 Billion	-10.99 Billion	-15.12 Billion

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Total Assets	369.38 Billion	298.92 Billion	314.48 Billion	314.48 Billion	300.1 Billion	280.75 Billion
Total Current Assets	177.5 Billion	116.42 Billion	139.64 Billion	139.64 Billion	142.19 Billion	137.55 Billion
Cash And Short Term Investments	62.65 Billion	9.3 Billion	30.23 Billion	30.23 Billion	47.59 Billion	36.4 Billion
Cash and Cash Equivalents	52.82 Billion	6.32 Billion	14.39 Billion	14.39 Billion	30.14 Billion	21.57 Billion
Short Term Investments	9.83 Billion	2.97 Billion	15.83 Billion	15.83 Billion	17.45 Billion	14.83 Billion
Net Receivables	66.46 Billion	63.1 Billion	75.26 Billion	75.26 Billion	61.96 Billion	70.52 Billion
Inventory	36.35 Billion	33.6 Billion	31.81 Billion	31.81 Billion	29.53 Billion	28.02 Billion
Other Current Assets	12.02 Billion	10.41 Billion	2.34 Billion	2.34 Billion	3.1 Billion	2.6 Billion
Total Non-Current Assets	191.88 Billion	182.5 Billion	174.84 Billion	174.84 Billion	157.9 Billion	143.2 Billion
Net PPE	109.98 Billion	98.23 Billion	90.96 Billion	90.96 Billion	81.46 Billion	75.02 Billion
Good Will And Intangible Assets	55.5 Billion	59.64 Billion	60.4 Billion	60.4 Billion	55.72 Billion	50.74 Billion
Good Will	-	-	4.46 Billion	4.46 Billion	-	-
Intangible Assets	55.5 Billion	59.64 Billion	55.94 Billion	55.94 Billion	55.72 Billion	50.74 Billion
Long-Term Investments	1.65 Billion	1.65 Billion	1.66 Billion	1.66 Billion	1.47 Billion	1.47 Billion
Tax Assets	22.56 Billion	20.96 Billion	20.38 Billion	20.38 Billion	18.81 Billion	15.61 Billion
Other Non Current Assets	2.17 Billion	2.01 Billion	1.43 Billion	1.43 Billion	430 Million	338 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	256.86 Billion	200.01 Billion	207.92 Billion	207.92 Billion	207.11 Billion	190.28 Billion
Total Current Liabilities	187.9 Billion	165.6 Billion	169.65 Billion	169.65 Billion	172.55 Billion	156.61 Billion
Account Payables	29.75 Billion	13 Billion	25.6 Billion	25.6 Billion	20.1 Billion	17.78 Billion
Tax Payables	5.9 Billion	5.96 Billion	7.11 Billion	7.11 Billion	12.29 Billion	9.61 Billion
Short Term Debt	5.45 Billion	10.16 Billion	6.47 Billion	6.47 Billion	6.61 Billion	6.28 Billion
Deferred Revenue	5.9 Billion	5.96 Billion	107.59 Billion	107.59 Billion	117.14 Billion	108.47 Billion
Other Current Liabilities	146.79 Billion	136.47 Billion	29.97 Billion	29.97 Billion	28.69 Billion	24.06 Billion
Total Non Current Liabilities	68.95 Billion	34.4 Billion	38.27 Billion	38.27 Billion	34.55 Billion	33.66 Billion
Long-Term Debt	51.6 Billion	16.76 Billion	20.52 Billion	20.52 Billion	19.92 Billion	19.41 Billion
Deferred Revenue Non Current	-	-	7.39 Billion	7.39 Billion	6.55 Billion	6.42 Billion
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	8.3 Billion	7.97 Billion	189 Million	189 Million	199 Million	193 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	112.52 Billion	98.91 Billion	106.56 Billion	106.56 Billion	92.99 Billion	90.47 Billion
Stock Holders Equity	112.52 Billion	98.91 Billion	106.56 Billion	106.56 Billion	92.99 Billion	90.47 Billion
Common Stock	446 Million	451 Million	451 Million	451 Million	451 Million	451 Million
Retained Earnings	112.15 Billion	99.05 Billion	104.83 Billion	104.83 Billion	91.73 Billion	88.11 Billion
Accumulated other comprehensive income	-73 Million	-585 Million	1.27 Billion	1.27 Billion	810 Million	1.9 Billion
Common Stock Equity	112.52 Billion	98.91 Billion	106.56 Billion	106.56 Billion	92.99 Billion	90.47 Billion
Capital Lease Obligation	-	-	5.72 Billion	5.72 Billion	-	-
Total Investments	11.49 Billion	4.63 Billion	17.5 Billion	17.5 Billion	18.92 Billion	16.31 Billion
Total Debt	57.06 Billion	26.92 Billion	27 Billion	27 Billion	26.53 Billion	25.7 Billion
Net Debt	4.23 Billion	20.6 Billion	12.61 Billion	12.61 Billion	-3.6 Billion	4.13 Billion

Balance Sheet Charts

Simbhaoli Sugars Limited

SIMBHALS

Full Analysis

Annual Balance Sheets
Nippon Shindo Co., Ltd.

5753

Full Analysis

Annual Balance Sheets
AvalonBay Communities, Inc.

0HJO

Full Analysis

Annual Balance Sheets
Citius Pharmaceuticals, Inc.

CTXR

Full Analysis

Annual Balance Sheets
Dürr Aktiengesellschaft

DUERF

Full Analysis

Annual Balance Sheets
The Okinawa Electric Power Company, Incorporated

OKEPF

Full Analysis

Annual Balance Sheets

Global Stocks Search

Novo Nordisk A/S (NOVO-B.CO)

Annual Balance Sheets

Balance Sheet Charts

Simbhaoli Sugars Limited

Nippon Shindo Co., Ltd.

AvalonBay Communities, Inc.

Citius Pharmaceuticals, Inc.

Dürr Aktiengesellschaft

The Okinawa Electric Power Company, Incorporated